USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Chronic Obstructive Pulmonary Disease Therapies Markets
U.S. Chronic Obstructive Pulmonary Disease Therapies Markets
RELEASE DATE
01-Aug-2002
01-Aug-2002
REGION
North America
North America
Research Code: A211-01-00-00-00
SKU: HC00835-NA-MR_04538
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
HC00835-NA-MR_04538
Description
This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely bronchodilators, anti-inflammatories and other emerging therapeutics. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Scope And Segmentation
- Disease Definition
- Symptoms
- Risk Factors
- Diagnosis
- Prevention And Treatment
- Drug Delivery Methods
- Disease Prevalence And Mortality
- Societal Economic Burden
- Challenges
- Market Drivers
- Market Restraints
Market Dynamics
- Demand Analysis
- Market And Technology Trends
Strategic Recommendations
- Strategies Overview
- Strategic Recommendations For Market Challenge 1
- Strategic Recommendations For Market Challenge 2
- Strategic Recommendations For Market Challenge 3
- Strategic Recommendations For Market Challenge 4
Frost & Sullivan Market Engineering Awards
- Market Engineering Leadership Award: Boehringer Ingelheim
- Technology Leadership Award: GlaxoSmithKline
- Product Differentiation Innovation Award: Sheffield Pharmaceuticals Inc.
- Business Development Strategy Award: Dey Inc.
- Technology Innovation Award: Sepracor Inc.
Overview
Competitive Analysis
Short-Acting Beta2 Agonist Market
Long-Acting Beta2 Agonist Market
- Introduction
- Market Drivers
- Market Restraints
- Market Engineering Analysis
- Revenue Forecast
Anticholinergics Market
- Competitive Structure
- Market Share Analysis
Methylxanthines Market
- Introduction
- Market Engineering Analysis
- Revenue Forecast
- Pricing Trends
- Competitive Structure
- Market Share Analysis
- Products Analysis-Existing
- Product Analysis-Emerging
Overview
Competitive Analysis
Inhaled Corticosteroids Market
Anti-Leukotrienes Market
Other Emerging Anti-Inflammatory Therapeutics Market
Overview
Causal Factors
Healthcare Infrastructure
Demographics
Popular Topics
This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely bronchodilators, anti-inflammatories and other emerging therapeutics. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A211-01-00-00-00 |
| Is Prebook | No |